Marketing-authorisation holder
Immunex Corporation
9 medicines in 1 country, as authorisation holder.
Group structure
Part of
ImmunexPharmaceutical groupOther companies in the group
United States2
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
9 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Enbrel25mg/0.5ml · Injection | Etanercept | United States | Marketed | 2007 |
| Enbrel50mg/ml · Injection | Etanercept | United States | Marketed | 2004 |
| ENBREL50mg/ml · Syringe | Etanercept | United States | Marketed | 1998 |
| ENBREL25mg/vial · Vial | Etanercept | United States | Marketed | 1998 |
| Enbrel50mg/ml · Injection | Etanercept | United States | Marketed | |
| Enbrel25mg/0.5ml · Injection | Etanercept | United States | Marketed | 2020 |
| Enbrel Mini50mg/ml · Injection | Etanercept | United States | Marketed | 2017 |
| LEVOPROME20mg/ml · Injectable | Levomepromazine | United States | Not marketed | |
| THIOPLEX15MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Thiotepa | United States | Not marketed | 1994 |